{ "items" : [
    { "id" : "http://dbpedia.org/resource/MedImmune"
      "properties" : {
        "http://www.w3.org/2000/01/rdf-schema#comment" : [ "MedImmune, LLC, headquartered in Gaithersburg, Maryland, became a wholly owned subsidiary of AstraZeneca in 2007. Since being acquired, MedImmune has remained a Maryland-based biotechnology development enterprise. It produces Synagis, a drug for the prevention of respiratory infections in infants, which accounted for US$ 1.06 billion of its US$ 1.2 billion in revenue for 2005, and FluMist, a nasal spray influenza vaccine introduced in 2004." ] ,
        "http://xmlns.com/foaf/0.1/name" : [ "MedImmune, LLC" ] ,
        "http://xmlns.com/foaf/0.1/homepage" : [ "http://www.medimmune.com/" ] ,
        "http://xmlns.com/foaf/0.1/depiction" : [ "http://en.wikipedia.org/wiki/Special:FilePath/MedImmune_logo.gif" ] ,
        "http://dbpedia.org/ontology/industry" : [ "http://dbpedia.org/resource/Pharmaceutical_industry" ] ,
        "http://dbpedia.org/ontology/location" : [ "http://dbpedia.org/resource/Gaithersburg,_Maryland",
          "http://dbpedia.org/resource/Maryland",
          "http://dbpedia.org/resource/United_States" ] ,
        "http://dbpedia.org/ontology/parentCompany" : [ "http://dbpedia.org/resource/AstraZeneca" ] ,
        "http://dbpedia.org/ontology/product" : [ "http://dbpedia.org/resource/Palivizumab",
          "http://dbpedia.org/resource/Live_attenuated_influenza_vaccine" ] ,
        "http://dbpedia.org/ontology/thumbnail" : [ "http://en.wikipedia.org/wiki/Special:FilePath/MedImmune_logo.gif?width=300" ] ,
        "http://dbpedia.org/ontology/type" : [ "http://dbpedia.org/resource/Subsidiary"] } } }
